Weekly Omnicell, Inc. (NASDAQ:OMCL) Ratings

June 27, 2018 - By Jane Lemasters

Omnicell, Inc. (NASDAQ:OMCL) Corporate Logo
Big Money Sentiment decreased to 1.03 in 2018 Q1. It has change of 0.09, from 2017Q4’s 1.12. The ratio fall due to Omnicell, Inc. positioning: 26 sold and 69 reduced. 30 funds bought holdings and 68 increased holdings. Investors holded 37.38 million in 2017Q4 but now own 37.13 million shares or 0.68% less.
Maryland-based Proshare Advsr Limited Company has invested 0% in Omnicell, Inc. (NASDAQ:OMCL). Penn Capital Mgmt Company, Pennsylvania-based fund reported 216,269 shs. Eagle Asset holds 0.3% or 1.29 million shs in its capital. State Of Tennessee Treasury Department holds 0.01% of its capital in Omnicell, Inc. (NASDAQ:OMCL) for 27,060 shs. Jefferies Ltd Co holds 6,717 shs or 0% of its capital. Miles Cap holds 0.14% or 5,727 shs in its capital. Parametric Portfolio Assoc Limited Liability Company reported 161,326 shs. Natl Bank Of Montreal Can has invested 0% of its capital in Omnicell, Inc. (NASDAQ:OMCL). Moreover, New York State Teachers Retirement has 0.01% invested in Omnicell, Inc. (NASDAQ:OMCL). Synovus Corporation holds 22,927 shs. Pier Capital Limited Liability Co accumulated 0.83% or 112,316 shs. The New York-based Metropolitan Life Ins Communication has invested 0% in Omnicell, Inc. (NASDAQ:OMCL). Raymond James holds 11,295 shs or 0% of its capital. 569,008 are owned by Oak Ridge Lc. Sio Capital Management Limited reported 1.83% stake.

Omnicell, Inc. registered $5.06 million net activity with 0 insider purchases and 12 insider sales since March 6, 2018. Kuipers Peter J. sold $33,304 worth of Omnicell, Inc. (NASDAQ:OMCL) or 724 shs on Thursday, April 12. 9,401 Omnicell, Inc. (NASDAQ:OMCL) shs with value of $471,778 were sold by DREW J CHRISTOPHER. Shares for $751,584 were sold by Seim Robin Gene. On Monday, April 16 11,284 shs were sold by JOHNSTON DAN S, worth $507,248. On Tuesday, June 19 Ngo Nhat H also sold $213,946 worth of Omnicell, Inc. (NASDAQ:OMCL). $25,544 worth of Omnicell, Inc. (NASDAQ:OMCL) shs were sold by PETERSMEYER GARY S.

Omnicell, Inc. (NASDAQ:OMCL) Ratings Coverage

In total 4 analysts cover Omnicell (NASDAQ:OMCL). “Buy” rating has 2, “Sell” are 0, while 2 are “Hold”. (NASDAQ:OMCL) has 50% bullish analysts. 5 are the (NASDAQ:OMCL)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. On Friday, February 2 PiperJaffray maintained Omnicell, Inc. (NASDAQ:OMCL) with “Neutral” rating. On Thursday, April 26 Cantor Fitzgerald maintained Omnicell, Inc. (NASDAQ:OMCL) with “Buy” rating. On Thursday, February 1 the rating was maintained by Cantor Fitzgerald with “Buy”. The stock rating was maintained by Oppenheimer with “Buy” on Monday, January 29. On Friday, February 2 the firm has “Hold” rating given by Craig Hallum. Listed here are Omnicell, Inc. (NASDAQ:OMCL) PTs and latest ratings.

26/04/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $63.0000 Maintain
02/02/2018 Broker: PiperJaffray Old Rating: Neutral New Rating: Neutral Old Target: $38 New Target: $44 Maintain
02/02/2018 Broker: Craig Hallum Rating: Hold Downgrade
01/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $63.0 Maintain
29/01/2018 Broker: Oppenheimer Rating: Buy New Target: $55.0 Maintain

OMCL hit $52.6 during the last trading session after $0.3 change.Currently Omnicell, Inc. is uptrending after 10.62% change in last June 27, 2017. OMCL has also 35,039 shares volume. OMCL underperformed by 1.95% the S&P 500.

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide.The firm is worth $2.05 billion. The firm operates through two divisions, Automation and Analytics, and Medication Adherence.The P/E ratio is 61.66. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.

Another two news for Omnicell, Inc. (NASDAQ:OMCL) were recently published by: Themiddlemarket.com on June 20, 2018 with title “Robotics developers are ripe for investment, says Innovation Works CEO Rich Lunak”. The other Prnewswire.com‘s article was titled “STOMPP Study Demonstrates Multimed Packaging Improves Medication Adherence” and published on June 12, 2018.

Omnicell, Inc. (NASDAQ:OMCL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: